Table 3. Outcomes for Patients With Neither Severe Cerebral Edema nor Highly Malignant EEG Treated With TTM at 33 °C or 36 °C.
Outcome | No. (%) | |
---|---|---|
TTM at 33 °C (n = 489) | TTM at 36 °C (n = 422) | |
Survived hospitalization | 171 (35.0) | 168 (39.8) |
ICU length of stay, median (IQR), d | 9 (5-18) | 8 (5-15) |
Hospital length of stay, median (IQR), d | 17 (11-26) | 16 (10-24) |
Modified Rankin Scale | ||
0 | 7 (4.1) | 2 (1.2) |
1 | 11 (6.4) | 10 (6.0) |
2 | 21 (12.3) | 23 (13.7) |
3 | 22 (12.9) | 24 (14.3) |
4 | 67 (39.2) | 67 (39.9) |
5 | 43 (25.1) | 42 (25.0) |
Cerebral performance category | ||
1 | 18 (10.5) | 11 (6.5) |
2 | 25 (14.6) | 26 (15.5) |
3 | 113 (66.0) | 122 (72.6) |
4 | 15 (8.8) | 9 (5.4) |
Died in hospital | 319 (65.2) | 253 (60.0) |
ICU length of stay, median (IQR), d | 3 (1-5) | 2 (1-5) |
Mode of death | ||
Rearrest, intractable shock, or multiple organ failure | 87 (27.3) | 100 (39.5) |
WLST, nonneurological reasons | 35 (11.0) | 64 (25.3) |
WLST, neurological prognosis | 174 (54.5) | 75 (29.6) |
Brain death | 22 (6.9) | 15 (5.9) |
Abbreviations: ICU, intensive care unit; IQR, interquartile range; TTM, targeted temperature management; WLST, withdrawal of life-sustaining therapies.